WO2003057897A3 - Recombinant protein expression - Google Patents
Recombinant protein expression Download PDFInfo
- Publication number
- WO2003057897A3 WO2003057897A3 PCT/IB2003/000299 IB0300299W WO03057897A3 WO 2003057897 A3 WO2003057897 A3 WO 2003057897A3 IB 0300299 W IB0300299 W IB 0300299W WO 03057897 A3 WO03057897 A3 WO 03057897A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- recombinant protein
- interest
- protein
- methods
- expression
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/67—General methods for enhancing the expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2003201727A AU2003201727A1 (en) | 2002-01-07 | 2003-01-07 | Recombinant protein expression |
EP03700428A EP1468105A2 (en) | 2002-01-07 | 2003-01-07 | Recombinant protein expression |
US10/500,883 US20050064545A1 (en) | 2002-01-07 | 2003-01-07 | Recombinant protein expression |
CA002471178A CA2471178A1 (en) | 2002-01-07 | 2003-01-07 | Recombinant protein expression |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0200250.9 | 2002-01-07 | ||
GBGB0200250.9A GB0200250D0 (en) | 2002-01-07 | 2002-01-07 | Recombinant protein expression |
GB0209013.2 | 2002-04-19 | ||
GBGB0209013.2A GB0209013D0 (en) | 2002-04-19 | 2002-04-19 | Recombinant protein expression |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003057897A2 WO2003057897A2 (en) | 2003-07-17 |
WO2003057897A3 true WO2003057897A3 (en) | 2003-11-27 |
Family
ID=26246917
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2003/000299 WO2003057897A2 (en) | 2002-01-07 | 2003-01-07 | Recombinant protein expression |
Country Status (5)
Country | Link |
---|---|
US (1) | US20050064545A1 (en) |
EP (1) | EP1468105A2 (en) |
AU (1) | AU2003201727A1 (en) |
CA (1) | CA2471178A1 (en) |
WO (1) | WO2003057897A2 (en) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100516389B1 (en) * | 2003-09-08 | 2005-09-23 | 한국과학기술원 | Composition for Protecting Proteins Degradation Comprising Small Heat Shock Proteins(sHSPs) and Method of Two-Dimensional Gel Electrophoresis Using the sHSPs |
GB0329681D0 (en) * | 2003-12-23 | 2004-01-28 | Delta Biotechnology Ltd | Gene expression technique |
DK2330200T3 (en) * | 2004-12-23 | 2017-07-24 | Albumedix As | GENE EXPRESSION TECHNIQUE |
GB0512707D0 (en) * | 2005-06-22 | 2005-07-27 | Delta Biotechnology Ltd | Gene expression technique |
WO2007058807A1 (en) * | 2005-11-10 | 2007-05-24 | Chaperone Technologies, Inc. | Screening method for dnak inhibitors |
US8722348B2 (en) | 2008-05-28 | 2014-05-13 | Wayne State University | Method and composition for a protein transduction technology and its applications |
DE102008035152A1 (en) * | 2008-07-28 | 2010-02-04 | Evocatal Gmbh | Chaperone toolbox |
EP2258854A1 (en) | 2009-05-20 | 2010-12-08 | FH Campus Wien | Eukaryotic host cell comprising an expression enhancer |
US20130224175A1 (en) * | 2010-08-24 | 2013-08-29 | North-West University | Recombinant therapeutic glycine n-acyltransferase |
CN102533835A (en) * | 2010-08-31 | 2012-07-04 | 上海交通大学 | Plasmid for heterologous protein solubility expression and preparation and application method thereof |
GB201101794D0 (en) | 2011-02-02 | 2011-03-16 | Fermentas Uab | Protein production |
EP2705143B1 (en) | 2011-05-02 | 2021-02-17 | Wayne State University | A protein-induced pluripotent cell technology uses thereof |
CN102925475B (en) * | 2012-11-22 | 2014-07-09 | 江南大学 | Novel method for realizing secreting expression of exogenous protein by using novel transfer signal |
PT3060237T (en) | 2013-10-25 | 2021-11-09 | Univ Wayne State | Methods, systems and compositions relating to cell conversion via protein induced in-vivo cell reprogramming |
WO2017215790A1 (en) * | 2016-06-17 | 2017-12-21 | National Hellenic Research Foundation | Systems for recombinant protein production |
KR102185312B1 (en) * | 2017-10-25 | 2020-12-02 | 재단법인 지능형 바이오 시스템 설계 및 합성 연구단 | A composition for solubilization of target proteins and use thereof |
US10829731B2 (en) | 2018-01-25 | 2020-11-10 | Alliance For Sustainable Energy, Llc | Biocatalysts for conversion of thermochemical waste streams |
CN111936629A (en) * | 2018-03-29 | 2020-11-13 | 弗门尼舍有限公司 | Process for producing vanillin |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0885967A2 (en) * | 1997-06-20 | 1998-12-23 | Hsp Research Institute, Inc. | Chaperone expression plasmids |
WO2000071723A2 (en) * | 1999-05-21 | 2000-11-30 | Roche Diagnostics Gmbh | Methods for regulating protein conformation using molecular chaperones |
-
2003
- 2003-01-07 WO PCT/IB2003/000299 patent/WO2003057897A2/en not_active Application Discontinuation
- 2003-01-07 AU AU2003201727A patent/AU2003201727A1/en not_active Abandoned
- 2003-01-07 CA CA002471178A patent/CA2471178A1/en not_active Abandoned
- 2003-01-07 EP EP03700428A patent/EP1468105A2/en not_active Withdrawn
- 2003-01-07 US US10/500,883 patent/US20050064545A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0885967A2 (en) * | 1997-06-20 | 1998-12-23 | Hsp Research Institute, Inc. | Chaperone expression plasmids |
WO2000071723A2 (en) * | 1999-05-21 | 2000-11-30 | Roche Diagnostics Gmbh | Methods for regulating protein conformation using molecular chaperones |
Non-Patent Citations (6)
Title |
---|
AMREIN KURT E ET AL: "Purification and characterization of recombinant human p50-csk protein-tyrosine kinase from an Escherichia coli expression system overproducing the bacterial chaperones GroES and GroEL.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES, vol. 92, no. 4, 1995, 1995, pages 1048 - 1052, XP002241051, ISSN: 0027-8424 * |
BEN-ZVI ANAT PERES ET AL: "Review: Mechanisms of disaggregation and refolding of stable protein aggregates by molecular chaperones.", JOURNAL OF STRUCTURAL BIOLOGY, vol. 135, no. 2, August 2001 (2001-08-01), pages 84 - 93, XP002241053, ISSN: 1047-8477 * |
CARRIO M M ET AL: "Protein aggregation as bacterial inclusion bodies is reversible", FEBS LETTERS, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 489, no. 1, 26 January 2001 (2001-01-26), pages 29 - 33, XP004239392, ISSN: 0014-5793 * |
MOGK A ET AL: "Identification of thermolabile Escherichia coli proteins: prevention and reversion of aggregation by DnaK and ClpB", EMBO JOURNAL, OXFORD UNIVERSITY PRESS, SURREY, GB, vol. 18, no. 24, 15 December 1999 (1999-12-15), pages 6934 - 6949, XP002148774, ISSN: 0261-4189 * |
THOMAS JEFFREY G ET AL: "ClpB and HtpG facilitate de novo protein folding in stressed Escherichia coli cells.", MOLECULAR MICROBIOLOGY, vol. 36, no. 6, June 2000 (2000-06-01), pages 1360 - 1370, XP002241052, ISSN: 0950-382X * |
VEINGER LEA ET AL: "The small heat-shock protein IbpB from Escherichia coli stabilizes stress-denatured proteins for subsequent refolding by a multichaperone network.", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 273, no. 18, 1 May 1998 (1998-05-01), pages 11032 - 11037, XP002241887, ISSN: 0021-9258 * |
Also Published As
Publication number | Publication date |
---|---|
AU2003201727A1 (en) | 2003-07-24 |
CA2471178A1 (en) | 2003-07-17 |
US20050064545A1 (en) | 2005-03-24 |
EP1468105A2 (en) | 2004-10-20 |
WO2003057897A2 (en) | 2003-07-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2003057897A3 (en) | Recombinant protein expression | |
Biedendieck et al. | Systems biology of recombinant protein production using Bacillus megaterium | |
WO2006042158A3 (en) | Methods and compositions for improving recombinant protein production | |
MX349285B (en) | Recombinant co-expression of vitamin k epoxide reductase subunit 1 to improve vitamin k dependent protein expression. | |
EP2330200A3 (en) | Gene expression technique | |
WO2003066818A3 (en) | Secretion, transcription and sporulation genes in bacillus clausii | |
US10745450B2 (en) | Peptides and uses thereof | |
CN105358694A (en) | Yeast promoters from pichia pastoris | |
BR0314512A (en) | Prokaryotic Recombinant Host Cell, Method for Producing a Plasmid, Plasmid and Method for Detecting a Plasmid Copy Mutation | |
Badura et al. | Development of genetic modification tools for Hanseniaspora uvarum | |
Wendler et al. | Comparative proteome analysis of Actinoplanes sp. SE50/110 grown with maltose or glucose shows minor differences for acarbose biosynthesis proteins but major differences for saccharide transporters | |
Niimi et al. | Identification of two proteins induced by exposure of the pathogenic fungus Candida glabrata to fluconazole | |
JP2020506722A5 (en) | ||
Gong et al. | Comparative proteomic analysis revealed metabolic changes and the translational regulation of Cry protein synthesis in Bacillus thuringiensis | |
CN101302517B (en) | Expressing method of human interleukin 7 in eucaryon host | |
DK1897939T3 (en) | Microorganism strain for production of recombinant proteins | |
US20190048044A1 (en) | Method for extracting 2',3'-cyclic nucleoside monophosphates | |
Ellis | Chaperomics: in vivo GroEL function defined | |
BRPI0516805A (en) | process for producing a heterologous protein using host cells of a yeast species | |
Hughes et al. | Proteome-determined type-specific proteins of Mycobacterium avium subspecies paratuberculosis | |
WO2006097945A3 (en) | A method for achieving high-level expression of recombinant human interleukin-2 upon destabilization of the rna secondary structure | |
CN102675445A (en) | Ubiquitin-like modified protein, preparation and application thereof | |
EP3564367A1 (en) | Method of selecting cells | |
US10947287B2 (en) | DNA coding sequence for human G-CSF | |
Miao et al. | Effect of peptidoglycan amidase MSMEG_6281 on fatty acid metabolism in Mycobacterium smegmatis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2471178 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003700428 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2003700428 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10500883 Country of ref document: US |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2003700428 Country of ref document: EP |